Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06051695 2026-05-26

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

Clinical Trials

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

RAINFOL-01

EVEREST-2

PARTHENON

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

ATTEST

SENTRY-HER2

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

SKB103 for Injection in Advanced Solid Tumors

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

SOLID-NK

A Study of TAK-505 in Adults With Solid Tumors

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

SKB118 Injection in Advanced Solid Tumors

mRNA-LNP

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

COAST

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

PRIMROSE

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

TEADES

A Study of ZL-1310 in Participants With Selected Solid Tumors

SKB105 for Injection in Advanced Solid Tumors

SKB565 for Injection in Advanced Solid Tumors

DOMISOL

Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors

Study of SGN1 in Patients With Advanced Solid Tumor

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

The Effects of Ginseng on Cancer-Related Fatigue

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

TEADCO

Mirdametinib + BGB-3245 in Advanced Solid Tumors

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Study in Advanced Solid Tumor Patients

Lead-212 PSV359 Therapy for Patients With Solid Tumors

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma